NCT01950364 2016-05-11A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell LymphomaMillennium Pharmaceuticals, Inc.Phase 1 Completed20 enrolled 59 charts